Popular on EntSun
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates - 397
- Stitt Entertainment Names Tristan Xavier Lead Stylist - 330
- ChargeOn Announces Conversational Payment Management Solution - 323
- Mecca to Mars: Earth's Escape? - 231
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 217
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 214
- Rehearsals Begin on 'The Call List' by Brian James Polak - 199
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 196
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING - 187
- Big Panic Records Announces "African Sunshine" by Believe, Shirley Jones & Omasta - 182
Similar on EntSun
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Mandeville Pests May Pose Serious Health Risks for Your Family
Market Maker Files 15c211 for CEN Biotech Inc
EntSun News/10807339
WINDSOR, Ontario - EntSun -- A market maker has filed a Form 211 Application with the Financial Industry Regulatory Authority ("FINRA") to request permission to quote and trade the securities of CEN Biotech, Inc. ("CEN Biotech" or the "Company") on OTC Markets. CEN Biotech is a Global Holding company focusing on Hemp (and it's legal derivatives), functional and innovative foods, nutrition, and cutting edge advancements in LED Lighting technology.
The Form 211 Application must be approved by FINRA in order to receive a ticker symbol and begin trading. CEN Biotech intends to submit an application to have its common stock quoted on OTC Markets as soon as practicable after the Form 211 Application is approved. However, there can be no assurance that FINRA will approve our Form 211 Application, and if it does approve it, there can be no assurance of the timing of such approval.
Forward-looking Statements
This press release may contain "forward-looking" statements. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions that could cause actual results to differ from those in the forward looking-statements. Potential risks include such factors as the inability to enter into agreements with parties with whom we are in discussions, the uncertainty of consumer demand for the Company's products or services, as well as additional risks and uncertainties that are identified and described in the Company's reports filed with the Securities and Exchange Commission. Results may differ materially from the forward-looking statements in this press release. Statements made herein are as of the date of this release and should not be relied upon as of any subsequent date. The Company does not undertake, and it specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.
More on EntSun News
About CEN Biotech, Inc.
CEN Biotech, Inc. is a Global Holding company focusing on Hemp (and it's legal derivatives), functional and innovative foods and nutrition, and cutting edge advancements in LED Lighting technology. www.cenbiotechinc.com
Press Contact
Brian Payne, Vice President / Corporate Secretary - Direct: (519) 419-4958, Extension 1505 - E:Mail: brian@cenbiotechinc.com
The Form 211 Application must be approved by FINRA in order to receive a ticker symbol and begin trading. CEN Biotech intends to submit an application to have its common stock quoted on OTC Markets as soon as practicable after the Form 211 Application is approved. However, there can be no assurance that FINRA will approve our Form 211 Application, and if it does approve it, there can be no assurance of the timing of such approval.
Forward-looking Statements
This press release may contain "forward-looking" statements. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions that could cause actual results to differ from those in the forward looking-statements. Potential risks include such factors as the inability to enter into agreements with parties with whom we are in discussions, the uncertainty of consumer demand for the Company's products or services, as well as additional risks and uncertainties that are identified and described in the Company's reports filed with the Securities and Exchange Commission. Results may differ materially from the forward-looking statements in this press release. Statements made herein are as of the date of this release and should not be relied upon as of any subsequent date. The Company does not undertake, and it specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.
More on EntSun News
- Emmy Nominee Sepideh Moafi And Peabody Award Winner Aasif Mandvi To Receive Cultural Impact Awards
- Originality Isn't Scarcity. Perspective Is
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Dwayne Buckle's Visionary 3D Feature Film Explores Power, Corruption, Truth & the Future of Humanity
About CEN Biotech, Inc.
CEN Biotech, Inc. is a Global Holding company focusing on Hemp (and it's legal derivatives), functional and innovative foods and nutrition, and cutting edge advancements in LED Lighting technology. www.cenbiotechinc.com
Press Contact
Brian Payne, Vice President / Corporate Secretary - Direct: (519) 419-4958, Extension 1505 - E:Mail: brian@cenbiotechinc.com
Source: CEN Biotech Inc.
Filed Under: Business
0 Comments
Latest on EntSun News
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
- Antoine Morgan steps into the "MARRIAGE BOX" and Things are getting interesting!
- French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
- LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
- Don Barnhart Brings His NFTG Tour Home as Delirious Celebrates One Year at Silver Sevens
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- Suits & Shoot Returns for 3rd Annual Noir Affair
- 'The Last Howl' Documentary Advocates for Conservation and Wildlife Preservation
- Venice FF 2026, Samantha Casella screens The Serpent's Caress
- 8th Edition of Filming Italy Venice Awards Cinema TalentÂ
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Mandeville Pests May Pose Serious Health Risks for Your Family
- The Hot Sardines Return to Frederick for a Night of Vintage Jazz at the Weinberg Center
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
